FIXER Inc. (TSE Growth: 5129), the Tokyo-listed generative AI vendor, told shareholders on 1 September 2026 that the year is going far worse than it said in April. The company cut its full-year sales forecast to ¥3.14bn from ¥4.35bn, a 27.9% reduction, and widened its expected operating loss to ¥2.44bn from ¥1.55bn, 57.7% deeper than the April plan. Net loss attributable to shareholders is now put at ¥2.48bn, or ¥158.00 a share, against a forecast loss of ¥105.77 a share four months earlier. Even after the cut, the year is worse than the one before it: FIXER lost ¥2.12bn on sales of ¥3.98bn in the year to August 2025.
Where the plan broke down
The single biggest culprit is Sovereign GaiXer, FIXER's on-premise generative AI product built for government agencies, municipalities and regulated companies that will not send sensitive data to the cloud. FIXER had forecast ¥951mn of sales from that line; it now expects ¥31mn, a ¥920mn shortfall. The company says product development itself slipped: stable production-environment operation, originally due in February, was not achieved until April 2026, delaying the start of actual sales and delivery. The sales operation behind it fell further behind: the dedicated sales team was not in place until July, marketing activity did not start in earnest until July, and the customer case studies needed to close deals were not ready until August, months later than planned.
A joint venture, Medical AI Solutions, missed its target by ¥345mn as its sales team and reseller network were slower to build than expected, worsened by delays in hospitals' subsidy approvals that pushed back order timing. Project-type government and public-body contracts came in ¥113mn short after FIXER lost some large tenders, and the cloud version of its flagship GaiXer product missed by ¥44mn as slow product updates and thin customer support drove cancellations. Resale and managed services were the bright spots, beating plan by a combined ¥214mn.
| Business line | Previous forecast | Revised forecast | Change |
|---|---|---|---|
| Sovereign AI (Sovereign GaiXer) | ¥951mn | ¥31mn | -¥920mn |
| Medical AI Solutions (JV) | ¥409mn | ¥64mn | -¥345mn |
| Project-type services | ¥798mn | ¥685mn | -¥113mn |
| SaaS (cloud GaiXer) | ¥220mn | ¥176mn | -¥44mn |
| Resale | ¥1,441mn | ¥1,551mn | +¥110mn |
| Managed services | ¥519mn | ¥623mn | +¥104mn |
| Other / consolidation adjustments | ¥10mn | ¥5mn | -¥5mn |
| Total | ¥4,348mn | ¥3,135mn | -¥1,213mn |
The company's own explanation
President Seiichi Matsuoka attached a personal letter to the filing rather than leaving the numbers to speak for themselves. He said the miss traces to one decision: keeping sales staff and resources tied up trying to fix the struggling cloud GaiXer business instead of shifting them to Sovereign GaiXer sooner. "The judgment on where, when and how much resource to place was mine to make, and I made it wrong," he wrote. Fixed costs that were not scaled back in time added ¥367mn to the operating loss.
The letter also addressed timing that will interest investors: FIXER's shares rose sharply on 28 and 31 August, the two trading days immediately before the 1 September guidance cut, and the company apologized for the concern that sequencing caused shareholders. Matsuoka said FIXER will now report its full-year outlook to the board monthly and write explicit rules for when a gap with published guidance triggers disclosure. The board is separately weighing a reduction to executive compensation, with details to follow once decided.
In July, FIXER moved roughly half its cloud-team staff onto Sovereign GaiXer. The company points to a joint AI development project with Tokyo Metropolitan Television announced 27 August and an adoption decision by the city of Soka in Saitama Prefecture announced the next day as early evidence the pivot is working, while cautioning these are "signs, not results" until they show up in revenue. Next year's forecast will arrive alongside the full-year earnings report due 9 October 2026.